Showing results (61-70 of 535) with videos related to
Sort By:
Pageof 54
Aesthetic Surgery Journal|April 1, 2009
Clinical results of botulinum toxin type a treatment of migraine headacheStephen D SilbersteinHeadache|May 22, 2010
OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical programDavid W Dodick, Catherine C Turkel, Ronald E DeGryse, et al.The Journal of Pain|December 3, 2014
Assessing clinically meaningful treatment effects in controlled trials: chronic migraine as an exampleDavid W Dodick, Catherine C Turkel, Ronald E DeGryse, et al.The New England Journal of Medicine|November 25, 2017
Fremanezumab for the Preventive Treatment of Chronic MigraineStephen D Silberstein, David W Dodick, Marcelo E Bigal, et al.JAMA|May 26, 2018
Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical TrialDavid W Dodick, Stephen D Silberstein, Marcelo E Bigal, et al.Neurology. Clinical Practice|September 4, 2015
Taking the headache out of migraineDavid Borsook, David W DodickThe American Journal of Medicine|April 22, 2005
Identifying migraine in primary care settingsRichard Sadovsky, David W DodickThe Lancet. Neurology|October 4, 2015
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b studyMarcelo E Bigal, David W Dodick, Alan M Rapoport, et al.Headache|June 14, 2023
Long-term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysisStewart J Tepper, Richard B Lipton, Stephen D Silberstein, et al.Neurology|November 23, 2005
Tearing without pain after trigeminal root section for cluster headacheHelen Lin, David W DodickPageof 54